Literature DB >> 16463404

Approval process and access to prescription drugs in Canada.

Carlo A Marra1, Larry D Lynd, Aslam H Anis, John M Esdaile.   

Abstract

Mesh:

Year:  2006        PMID: 16463404     DOI: 10.1002/art.21709

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  5 in total

1.  Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada.

Authors:  Lingyun Lu; Harlan M Krumholz; Jack V Tu; Joseph S Ross; Dennis T Ko; Cynthia A Jackevicius
Journal:  Am Heart J       Date:  2014-02-26       Impact factor: 4.749

2.  Cost shifting and timeliness of drug formulary decisions in atlantic Canada.

Authors:  Andrea C Scobie; Neil J Mackinnon
Journal:  Healthc Policy       Date:  2010-02

3.  Re: "cost shifting and timeliness of drug formulary recommendations in atlantic canada," healthcare policy, vol. 5, no. 3, 2010.

Authors: 
Journal:  Healthc Policy       Date:  2010-08

4.  Impact of drug policy on regional trends in ezetimibe use.

Authors:  Lingyun Lu; Harlan M Krumholz; Jack V Tu; Joseph S Ross; Dennis T Ko; Cynthia A Jackevicius
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-06-03

5.  Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand.

Authors:  Jacques LeLorier; Nugek S B Rawson
Journal:  Can J Cardiol       Date:  2007-07       Impact factor: 5.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.